Fresenius Becomes Latest To Launch US Stelara Rival

Also Introduces Formycon-Partnered Otulfi Ustekinumab Biosimilar In Europe

 
• By Dave Wallace
  
Fresenius will be looking to stand out in a crowded market (Shutterstock)

More from Biosimilars

More from Business